114 related articles for article (PubMed ID: 1286739)
1. The effect of a single oral morning dose of nizatidine and ranitidine on intragastric pH under basal conditions and after pentagastrin stimulation.
Lazzaroni M; Sangaletti O; Bianchi Porro G
J Int Med Res; 1992 Nov; 20(6):454-60. PubMed ID: 1286739
[TBL] [Abstract][Full Text] [Related]
2. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
4. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
Lazzaroni M; Bianchi Porro G
Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
6. [Clinical studies on acid inhibition by ranitidine given simultaneously with pentagastrin].
Simon B; Bergdolt H; Dammann HG; Müller P
Arzneimittelforschung; 1992 Feb; 42(2):133-5. PubMed ID: 1610422
[TBL] [Abstract][Full Text] [Related]
7. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
[TBL] [Abstract][Full Text] [Related]
8. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
[TBL] [Abstract][Full Text] [Related]
9. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[TBL] [Abstract][Full Text] [Related]
10. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
Fullarton GM; Macdonald AM; McColl KE
Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
[TBL] [Abstract][Full Text] [Related]
11. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
12. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
[TBL] [Abstract][Full Text] [Related]
13. The new histamine H2-receptor antagonist ranitidine. Duration of action.
Dammann HG; Simon B
Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of oral nizatidine and ranitidine on gastric volume and pH in patients undergoing gynaecological laparoscopy.
Popat MT; Dyar OJ; Blogg CE
Anaesthesia; 1991 Oct; 46(10):816-9. PubMed ID: 1683179
[TBL] [Abstract][Full Text] [Related]
15. Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E2 and serum gastrin concentrations in healthy volunteers.
Thompson A; Kirdeikis P; Jamali F; Tavernini M; Zuk L; Marriage B; Simpson I; Mahachai V
J Gastroenterol Hepatol; 1995; 10(5):546-54. PubMed ID: 8963030
[TBL] [Abstract][Full Text] [Related]
16. Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
Coruzzi G; Coppelli G; Frati P; Bertaccini G
Pharmacol Res; 1998 Dec; 38(6):469-73. PubMed ID: 9990656
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
18. Acid-inhibitory potency of ranitidine in diabetic rats.
Chang FY; Chen TS; Lee SD; Yeh GH; Doong ML; Wang PS
Pharmacology; 2002 Sep; 66(1):5-10. PubMed ID: 12169759
[TBL] [Abstract][Full Text] [Related]
19. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
[TBL] [Abstract][Full Text] [Related]
20. Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.
Segawa Y; Takei M; Omata T; Tsuzuike N; Yamaji Y; Kurimoto T; Ozeki M; Tagashira E
Arzneimittelforschung; 1991 Sep; 41(9):950-3. PubMed ID: 1796923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
